Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Albert Geller, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Daniel Geller and Stephen Faraone.
Connection Strength

1.121
  1. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003 Nov; 160(11):1919-28.
    View in: PubMed
    Score: 0.286
  2. Reexamining Tic persistence and Tic-associated impairment in Tourette's Disorder: findings from a naturalistic follow-up study. J Nerv Ment Dis. 2004 Nov; 192(11):776-80.
    View in: PubMed
    Score: 0.077
  3. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004 Jul; 110(1):4-13.
    View in: PubMed
    Score: 0.075
  4. Re-examining comorbidity of Obsessive Compulsive and Attention-Deficit Hyperactivity Disorder using an empirically derived taxonomy. Eur Child Adolesc Psychiatry. 2004 Apr; 13(2):83-91.
    View in: PubMed
    Score: 0.074
  5. Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder? CNS Spectr. 2003 Apr; 8(4):259-64.
    View in: PubMed
    Score: 0.069
  6. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2002 Jul; 59(7):649-56.
    View in: PubMed
    Score: 0.065
  7. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):52-8.
    View in: PubMed
    Score: 0.063
  8. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis. 2001 Jul; 189(7):471-7.
    View in: PubMed
    Score: 0.061
  9. Disentangling chronological age from age of onset in children and adolescents with obsessive--compulsive disorder. Int J Neuropsychopharmacol. 2001 Jun; 4(2):169-78.
    View in: PubMed
    Score: 0.060
  10. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety. 2000; 11(4):163-8.
    View in: PubMed
    Score: 0.055
  11. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Sep; 56(9):842-7.
    View in: PubMed
    Score: 0.054
  12. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry. 1998 Oct; 39(7):1037-44.
    View in: PubMed
    Score: 0.050
  13. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996 Sep; 153(9):1147-53.
    View in: PubMed
    Score: 0.043
  14. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan; 162(1):22-7.e2.
    View in: PubMed
    Score: 0.033
  15. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr; 158(4):611-7.
    View in: PubMed
    Score: 0.015
  16. Tourette disorder and ADHD. Adv Neurol. 2001; 85:57-77.
    View in: PubMed
    Score: 0.015
  17. Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth. J Nerv Ment Dis. 2000 Sep; 188(9):583-8.
    View in: PubMed
    Score: 0.014
  18. Absence of cardiovascular adverse effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):573-7.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.